Indo Cotspin Ltd
Indo Cotspin Ltd (ICL) last traded at ₹35.5, a market capitalisation of ₹25.3 crore. Over the past 52 weeks the stock has ranged between ₹22 and ₹44. Indo Cotspin Ltd last reported results for the quarter ended Jun 2026, with sales of ₹2 crore and net profit of ₹0 crore. Figures are as of 25 Aug 2026 and are not real time.
Indo Cotspin Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Indo Cotspin Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2 cr, up 4.7% from ₹1.91 cr a year earlier.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.26 | 10.26 | 6.35 | 1.91 | 6.59 | 10.14 | 5.97 | 2 |
| Expenses | 5 | 10.06 | 6.18 | 1.79 | 6.44 | 9.98 | 5.86 | 1.89 |
| Operating profit | 0.26 | 0.2 | 0.17 | 0.12 | 0.15 | 0.16 | 0.11 | 0.11 |
| OPM % | 4.94% | 1.95% | 2.68% | 6.28% | 2.28% | 1.58% | 1.84% | 5.50% |
| Other income | 0.23 | 0.01 | -0.01 | 0 | 0 | 0 | 0 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.01 | 0.01 |
| Depreciation | 0.14 | 0.14 | 0.14 | 0.11 | 0.12 | 0.12 | 0.13 | 0.1 |
| Profit before tax | 0.35 | 0.07 | 0.02 | 0.01 | 0.02 | 0.01 | -0.03 | 0.01 |
| Tax % | 25.71% | 28.57% | 100.00% | 0.00% | 0.00% | 100.00% | 33.33% | 0.00% |
| Net profit | 0.26 | 0.05 | -0.01 | 0 | 0.01 | 0.01 | -0.03 | 0 |
| EPS (₹) | 0.36 | 0.07 | -0.01 | 0.00 | 0.01 | 0.01 | -0.04 | 0.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Indo Cotspin Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 7.85 | 13.71 | 13.21 | 16.62 | 24.89 | 24.47 | 24.7 |
| Operating profit | 0.35 | 0.51 | 0.6 | 0.88 | 0.78 | 0.57 | 0.53 |
| OPM % | 4.46% | 3.72% | 4.54% | 5.29% | 3.13% | 2.33% | 2.15% |
| Net profit | 0.05 | 0.14 | 0.25 | 0.07 | 0.4 | -0.01 | -0.01 |
| EPS (₹) | 0.07 | 0.20 | 0.35 | 0.10 | 0.56 | -0.01 | -0.02 |
TTM is the trailing twelve months to the most recent quarter.
Indo Cotspin Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 26%
- 3 Years
- 23%
- TTM
- 4%
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 14%
- TTM
- -103%
- 10 Years
- 16%
- 5 Years
- 29%
- 3 Years
- 8%
- 1 Year
- 24%
- 10 Years
- 0%
- 5 Years
- 1%
- 3 Years
- 2%
- Last Year
- 0%
Indo Cotspin Ltd shareholding pattern
Promoters held 59.21% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 59.21% | 59.21% | 59.21% | 59.21% | 59.21% | 59.21% | 59.21% | 59.21% |
| Public | 40.80% | 40.80% | 40.79% | 40.80% | 40.79% | 40.78% | 40.78% | 40.79% |
| No. of shareholders | 2,972 | 3,294 | 3,114 | 2,995 | 2,968 | 2,951 | 2,911 | 2,772 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Indo Cotspin Ltd corporate filings
- This is to inform you that the Company M/s Indo Cotspin Limited has conducted 32nd Annual General Meeting (AGM) on Monday 10th, August, 2026 at 01:00 P.M. (IST) through Video Conferencing ....AGM/EGMmedium impact
Cruxal's analysis: Indo Cotspin Limited has successfully passed 11 resolutions at its 32nd Annual General…
Read the full analysis - In accordance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith summary of proceedings ....AGM/EGMmedium impact
Cruxal's analysis: Indo Cotspin Limited has concluded its 32nd Annual General Meeting, where shareholders…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Indo Cotspin Ltd
Cruxal reads every Indo Cotspin Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.